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Mammahan pancreatic phosphohpase AZ (PLA:-I) has Its specific receptor through which PLA?-I Induces a variety of biologtcal responses. In this 
study, a fundamental relationship between the enzymatic and the receptor-bmdmg acttvtttes of PLA?-I mas mvesttgated. The specific bmding of 
PLA,-I to the receptor was found to be independent of Ca” whtch is requisite for the PLAz activity. On the basis of this observation, we destgned 
and produced mutant PLA?-Is without Ca”-bindmg abilities m order to demonstrate that the structural requirement for the enzymatic activity 
of PLA,-I is not Identical with that for its receptor-bindmg reaction. These mutant PLA,-Is lost almost all enzymatic activity through a disturbance 
at the Ca”-binding site, as expected. but still retained a substantial affimty to the receptor, allowing us to conclude that the receptor-binding reaction 
of PLA?-I is separable from its catalytic action. 
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1. INTRODUCTION 
Phospholipase A, (PLA,; EC 3.1.1.4) catalyzes the 
hydrolysis of the fatty acid ester bond at the m-2 posi- 
tion in phospholipids. Mammalian secretory PLA,s so 
far identified are classified into two groups, groups I 
and II, on the basis of their characteristics in primary 
structure. The mammalian group I PLA, (PLA,-I) is 
also called pancreatic PLA, due to its high abundance 
especially in pancreas. Although PLA,-I has been con- 
sidered to play a digestive role in mammals for a long 
time, recent studies show that this enzyme has a specific 
receptor on mammalian cells and elicits a variety of 
biological responses in a receptor-mediated manner [l- 
51. The structural requirement for the receptor binding 
of PLA,-I is proved to be very strict 133; group II PLA,s 
as well as non-mammalian group I PLA,s are not recog- 
nized by the receptor, and furthermore, an enzymati- 
tally inactive precursor of PLA,-I (proPLA,-I) could 
not be a ligand even though the backbone structures of 
these PLA+ are almost superimposable with that of 
mature PLA,-I [668]. These facts raise questions as to 
what kind of structural properties of PLA, are crucial 
for the receptor-binding abilities and as to the ligand 
recognition mechanism of this receptor. As a first step 
to answering these questions on a molecular basis, we 
investigated the relationship between the enzymatic and 
receptor-binding activities of PLA,-I and discriminated 
these in terms of Ca’+ requirement. A successful gener- 
ation of an enzymatically inactive mutant PLA2-I with 
a specific binding affinity to the receptor clearly indi- 
cates that the receptor binding and the enzymatic action 
are distinctive properties of PLA,-I. 
The receptor-bmdmg assay was performed as descrtbed prevtously 
[3] except that the bovine MDBK cell line (ATCC. CCL 22) was used 
as receptor expressmg cells. The cells (I x 10’) were plated in culture 
dishes of 2.5 cm m dtameter and grown in RPM1 1640 medium supple- 
mented with 10% fetal bovme serum, 100 U/ml pemcillin. and 100 
pg/ml streptomycm. Bmding affimttes of recombmant PLA:-Is were 
evaluated on their displacement potencies agamst the specific receptor 
bmding of “‘I-labeled porcme PLA,-I, and quantitatively expressed 
as the concentration of unlabeled PLA,-I at which the half-maximal 
displacement is achieved. termed IC,,, [3]. PLAz acttvittes of recombi- 
nant PLA?-Is were determmed usmg [“C]linoleoyl-phosphatidyletha- 
nolamme as a substrate [9]. 
For evaluating the effect of Ca” on the PLA, activtty. the enzyme 
activity has measured m Hanks’ solution (137 mM NaCI. 5 4 mM 
KCI, 0.34 mM Na?HPO,. 0.44 mM KH,PO,. 0.41 mM MgSO,. 0.49 
mM MgCI,. 1 3 mM CaCI:. and 5.6 mM glucose) in the presence or 
absence of 2 mM EDTA. 
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2.3. Construction of mutant PLAz expression plasmids 
A site-specific mutagenests of PLA?-I cDNA was performed by an 
overlap extension techmque reported by Ho et al [lo]. For mtroducmg 
a mutation. mutagenic ohgonucleotides were synthesized. oligonucle- 
ottdes used for generating D49N mutant (Asp-49 to Asn) were 5’- 
GCTGCCAGACACAT&ACAAC-3’ (sense strand) and 5’-GTCAT- 
AGCAGTTGTTATGTG-3’ (antisense strand). and those for D49K 
mutant (Asp-49 to Lys) were 5’-TGCCAGACACATAAGAACTGC- -- 
3’ (sense strand) and S’-GTCATAGCAGTTgT_TATGTGT-3’ (anti- 
sense strand). Nucleotide residues underlined denote introduced mu- 
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tattons. Usmg the human PLA,-I expression plaamtd pAM87- 
HuPLA? [I I] as a template. 5’- and 3’-portions of PLA,-I cDNA were 
separately amplified by the polymerase cham reaction (PCR) usmg the 
mismatch- contaming ohgonucleotides and oligonucleotides that hy- 
bridized at 5’ and 3’ ends of the cDNA After the PCR. the amphfied 
DNAs corresponding to the mutagemzed 5’ and 3’-portions of PLA, 
cDNA, which have a sequence overlap at the mutagemzed regron, 
were purified on an agarose gel, mixed, and then subjected to PCR 
wtth the primers correspondmg to 5’ and 3’ ends of the cDNA to 
produce a full length cDNA with site-specihc mutation(s). cDNA 
fragments thus obtained were treated with Klenow fragment, digested 
with .Y/rol. and then Inserted between .Y/roI and PruII restrictron sttea 
of PAM82 The expected sequence substitutions as well as the absence 
of artifictal alternations in the cDNA structure during PCR were 
ascertamed by sequencmg the complete region of cDNA Insert in the 
expression plasmid with a Sequenase sequencing kit version 2 0 
(United States Biochemicals). 
2.3 E.~prr.wut~ und pur~fic~twn o/ recombrmmt PLA,-Is 
Transformation of Suc~ch~onr~ce~ ~~c~r~.~c AH22 and culture of 
recombinant yeast were carried out as described by Kanda et al. [I I]. 
Secreted proPLA?-I m 700 ml of culture supernatant was absorbed to 
CM-cellulose CM51 equrhbrated atth IO mM 4-morpholme ethane- 
sulfonate buffer (pH 6.0) overmght at 4°C under gentle stnrmg. The 
proPLAL was eluted from the resin with a stepwrae increase in NaCl 
concentration to 0.2 M m the same buffer described above. concen- 
trated with Centrtcon 10 (Amicon). and activated through dtgestion 
wtth trypsin (lO,&ml) m 50 mM Tris-HCI. pH 8 0 at 37°C for 30 mm. 
The mature PLA2-I thus obtained was purified by high-performance 
liquid chromatography (COSMOSIL, 5C,-300, 4 6 x 150 mm) vvtth a 
linear gradient of acetomtrile from 15% to 559 in 0. I% oftrifluoroace- 
tic acid The final purtty of the recombmant protem was assessed by 
high-performance liquid chromatography and polyacrylamtdc gel 
electrophorests m the presence of sodmm dodecyl sulfate. and its 
concentration was determined through ammo acid analysis usmg a 
Hitachi ammo acid analyzer (model 835). 
3. RESULTS AND DISCUSSION 
3.1. Ck’ dependence of tfle receptor binding 
First, we examined the requirement of Ca7+ in recep- 
tor-binding reaction: if the receptor-binding reaction is 
a Ca”-independent process, it would be a remarkable 
contrast to the catalytic action of PLA,-I since PLA, 
activity is known to require a submillimolar concentra- 
tion of Ca”. Fig. 1 shows that the removal of divalent 
cations by the addition of EDTA did not influence the 
binding ability of PLA,-I whereas the enzymatic activity 
of PLA,-I was almost lost under the same conditions, 
as expected. Since PLA,-I undergoes some conforma- 
tional changes upon Ca” binding [12], the results indi- 
cate that the Ca”-induced conformational alternation 
does not affect the receptor-binding reaction. This obvi- 
ous difference in the Ca” dependence beween the recep- 
tor-binding and enzymatic activities means that these 
two properties are distinctive. and strongly suggests that 
the Ca’+ binding site is a possible target for generating 
a mutant PLA,-I retaining the receptor-binding ability 
but losing its enzymatic activity. If we can successfully 
produce such a mutant PLA,-I. this mutant provides us 
with solid evidence that the receptor-binding and enzy- 
matic activities are separable properties of the PLA,-I 
molecule. Furthermore, this mutant would serve as a 
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Frg 1. Effects of Ca” on PLA,-I enzymatic activtty (A) and on its 
specific bmdmg to PLA,-I receptor (B) (A) 80 ng of human PLA,-I 
has Incubated with [“CJhnoleoyl-pho,Chattdylethanolamine (IOpM) 
m Hanks’ solution at 37°C for 30 min m the presence (+) or the ab- 
sence t-) of EDTA (final 2 mM). The control wa5 defined as the 
activtty in the absence of EDTA. (B) MDBK cell\ here Incubated uith 
I nM [““I]PLAI-1 (porcme) m Hanks’ solution at room temperature 
for 3 h m the presence (+) or absence (-) of EDTA, and then the 
specific binding was measured. 
novel tool for analyzing the physiological roles of PLA,- 
I and its receptor in a practical respect; this enables us 
to compare cellular events evoked by wild-type and 
these mutant PLA,-Is and thereby elucidate which cellu- 
lar events require PLA, activity for eliciting the recep- 
tor-mediated responses, if any. Therefore. we decided to 
pursue production of this type of mutant PLA,-Is and 
examination of their properties. 
3.2. Receptor-bittding and enz?wlutic activit>~ qf mrtunt 
PLA,-Is 
From previous studies [13.14]. it is now evident that 
Asp-49 in PLA?-I is directly involved in Ca’+ binding. 
Van den Berge et al. examined the role of Asp-49 in 
porcine PLA,-I using a site-specific mutagenesis tech- 
nique and found that a mutant PLA,-I with an amino 
acid residue substitution at Asp-49 to Lys or Glu lost 
the enzymatic activity almost completely through the 
reduction of Ca’+ binding ability [ 151. This finding sug- 
gests that any amino acid residue replacement at posi- 
tion 49 probably causes inactivation of PLA,-I due to 
lowering Cal+ binding. Thus, we designed two mutants 
of human PLA,-I expected to lose their Ca” binding 
ability; Asp-49 ;n the wild-type PLA,-I was converted 
into Asn or Lys in a mutant, designated D49N or 
D49K, respectively. We produced these as well as the 
wild-type enzyme utilizing a recombinant expression 
system in yeast and they were purified to homogeneity 
by a combination of some chromatographic steps after 
activation of secreted proPLA,-I with trypsin as de- 
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Fig. 2. Displacement assay of recombinant human PLAZ-Is. MDBK 
cells were incubated with “‘I-labeled PLA,-I (porcme. I .2 nM) and 
each recombmant unlabeled PLA2-I (wild-type (i). or D49N (0). or 
D49K (c). or proPLAz (m)) at 4°C for 3 h. Bound radiolabeled PLA,-I 
was measured as described previously [3]. The data represent the 
means of three independent experiments. 
scribed in section 2. It is already proved that the recom- 
binant wild-type PLA,-I thus obtained is enzymatically 
active and indistinguishable from the native enzyme as 
far as examined [l 11. 
First, we measured the binding affinities of the re- 
combinant PLA?-Is to the receptor by the displacement 
assay (Fig. 2). From the relationships between “‘I-la- 
beled PLA,-I displacements and added amounts of the 
recombinant PLA?-Is. the binding affinities were esti- 
mated and quantitatively expressed as IC,, as shown in 
Table I together with their enzymatic activities. As ex- 
pected, the enzyme activities of D49N and D49K were 
as low as that of proPLA,-I (less than 1% of that of the 
wild-type PLA,). However. in contrast to proPLA,-I, 
the mutant PLA,-Is certainly retained substantial recep- 
tor-binding ability; IC,,s of D49N and D49K were 3.8 
and 20.8 times higher, respectively, than that of the 
wild-type PLA,-I, although proPLA,-I had virtually no 
binding ability to the receptor. These results indicate 
Table I 
Half-maximal mhibitory concentrations (IC,,,s) and enzymatic activi- 
ties of recombmant human PLA,-Is 
PLA,-Is Bmding activity” 
IC,,, value (M) 
Enzymatic activityh 
(% of wild-type) 
Wild-type 
D49N 
D49K 
proPLAz 
4.8 x lo-” 100 
1.8 x 1om8 0.62 
1.0 x IO_’ 0 51 
>3 x lo-’ 0.47 
’ IC,,,s were calculated from the displacement curves of the “‘I-labeled 
porcme PLA,-I binding to the receptor as shown in Fig. 2. 
‘Enzymatic activities were measured using [‘JC]lmoleoyl-phosphati- 
dylethanolamme as a substrate as described [9]. 
that disruption of a structural element required for the 
enzymatic activity is not necessarily accompanied with 
loss of the receptor-binding activity. In other words. the 
structure around the Ca”-binding site appeared not to 
be critical for the receptor-binding activity although the 
introduced structural perturbation at the Ca”-binding 
site by the mutation affects the receptor-binding ability 
to some extent. The decrease in the affinity of mutant 
PLA?-Is to the receptor suggested that there is a possi- 
bility of sharing the structural motif(s) necessary for the 
enzymatic action and the receptor binding in part as 
anticipated from the behavior of proPLA,-I. However, 
it can be unequivocally concluded that a Ca”-induced 
conformational change of PLA,-I is not essential for 
receptor binding at all. 
Although we do not know of differences in the actual 
three-dimensional structures of these mutants and the 
wild-type PLA,-I in solution, it is very likely that the 
structure of the wild-type PLA,-I is more suitable for 
both the enzymatic activity and receptor-binding than 
those of the mutants. In this respect. the fact that D49K 
retained a lower receptor-binding activity than D49N 
may be explained by the assumption that the substitu- 
tion of negatively charged residue (Asp) in the wild-type 
PLA,-I to a positive one (Lys) causes a larger perturba- 
tion to the overall PLA,-I structure than that to a neu- 
tral residue (Asn). 
A major concern in a series of physiological studies 
on the PLA,-I-mediated responses is how to discrimi- 
nate receptor-mediated consequences from a direct ef- 
fect of the PLAz activity. To this end the mutant PLA,-I 
(e.g. D49N) opens the way to examine cellular events 
evoked by PLA,-I regardless of the enzyme activity and 
thereby makes it possible to gain a deeper insight to the 
PLA,-I receptor-mediated reactions. 
3.3. Conclusions 
We successfully generated mutant PLA,-Is which re- 
tained receptor-binding ability but lost enzyme activity 
by the destruction of the Ca”-binding site. Although it 
is difficult to conclusively define the region in PLA,-I 
molecule responsible for the receptor-binding at pres- 
ent, these mutant PLA,-Is gave us evidence that the 
requirements for the enzymatic and receptor-binding 
activities are not completely identical. In addition, these 
mutant PLA,-Is would provide us with a powerful tool 
for further investigations on the signal transduction 
mechanisms of PLA,-I mediated by the receptor. 
Ar~rlo,~lc~~rr,icrtts We thank A. Terawaki and A. Kanda of our lab- 
oratory for their techmcal assistance. 
REFERENCES 
[l] Arita. H.. Hanasaki. K , Nakano. T., Oka. S.. Teraoka. H. and 
Matsumoto, K (1991) J. Biol. Chem. 266. 19139-19141. 
[2] Hanasaki, K. and Arita. H. (1992) Biochim. Biophys. Acta 1127. 
233-341 
3.51 
Volume 323. number 3 FEBS LETTERS June 1993 
[3] Hanasakt, K. and Arita. H. (1992) J. Biol Chem. 267,64146420. 
[4] Kanemasa. T.. Hanasaki, K. and Arita. H. (1992) Btochim. BIO- 
phys. Acta 1125. 21@214. 
[5] Tohkm. M.. Kishmo. J.. Ishizakt, J. and Arita, H. (1993) J. Biol. 
Chem. 268. 286552871 
[6] Wery. J.P, Schecnz, R.W., Ciawson. D.K . Bobbitt. J L . Dow. 
E.R., Gamboa, G , Goodson. Jr. T.. Hermann. R.B.. Kramer. 
R.M., McClure. D.B . Mthelich, E.D.. Putnam. J.E.. Sharp, J.D., 
Stark, D.H., Tester. C, Warrick, M.W. and Jones. N D. (1991) 
Nature 352. 79982. 
[7] White, S.P., Scott. D.L., Otwmowskr. 2.. Gelb. M.H. and Slgler. 
P.B. (1990) Science 250. 1560&l 563 
[8] DiJkstra. B.W.. van Nes, G J.H.. Kalk. K.H.. Brandenburg, N P., 
HOI. W.G.J. and Drenth. J. (1982) Acta Cryst. B38. 7933799. 
[9] Tanaka, K . Matsutam. S.. Matsumoto. K. and Yoshtda. T. 
(1992) J. Antibiotics 45, 1071-1078. 
[IO] Ho. S.N., Hunt, H.D.. Horton, R.M.. Pullen, J.K. and Pease. 
L.R (1989) Gene 77. 51-59. 
[ll] Kanda. A.. Tamakt. M.. Nakamurd. E.. Teraoka. H. and 
Yoshtda. N. (1992) Biochrm. Biophys. Acta 1171. l-10 
[l?] Pteterson. W.A.. Volwerk. J.J. and de Haas. G.H. (1974) Bio- 
chemistry 13. 1439~1445. 
[13] Fleer. E.A M.. Verheq, H.M. and de Haas. G.H (1981) Eur. J. 
Btochem. 113. 2833288. 
[14] DiJkstra. B.W.. Kalk. K H. HOI. W.G.J. and Drenth, J. (1981) 
J Mol B~ol. 147. 97-123. 
[15] van den Berge, C J , Slotboom. A.J . Verhetj, H M. and de Haas. 
G H. ( 1988) Eur. J Blochem. 176. 3533357 
352 
